REQUEST A DEMO
Total
USD $0.00
Search more companies

Se Pharmacopoeial Center State-Owned Co (Ukraine)

Main Activities: Scientific Research and Development Services
Full name: Se Pharmacopoeial Center State-Owned Co Profile Updated: September 10, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Russian Download a sample report

Se Pharmacopoeial Center State-Owned Co is based in Ukraine. The head office is in Kharkiv. The company operates in the Scientific Research and Development Services sector. Se Pharmacopoeial Center State-Owned Co was incorporated on May 26, 1998. Se Pharmacopoeial Center State-Owned Co currently employs 84 (2024) people. In its most recent financial highlights, the company reported a net sales revenue increase of 76.8% in Q12026. A growth of 22.06% was recorded in its total assets. In, 2026, the company’s net profit margin increased by 10.64%.

Headquarters
33 Vul. Astronomichna
Kharkiv; Kharkiv Oblast; Postal Code: 61085

Contact Details: Purchase the Se Pharmacopoeial Center State-Owned Co report to view the information.

Basic Information
Total Employees:
Purchase the Se Pharmacopoeial Center State-Owned Co report to view the information.
Financial Auditors:
Purchase the Se Pharmacopoeial Center State-Owned Co report to view the information.
Incorporation Date:
May 26, 1998
Key Executives
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Se Pharmacopoeial Center State-Owned Co report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency UAH. Absolute financial data is included in the purchased report.
Net sales revenue
76.8%
Total Operating Revenue
76.69%
Operating Profit
1820%
EBITDA
633.47%
Net Profit/Loss for the Period
1474.38%
Total Assets
22.06%
Total Equity
8.51%
Operating Profit Margin
13.27%
Net Profit Margin
10.64%
Return on Equity (ROE)
36.49%
Quick Ratio
0.15%
Cash Ratio
0.16%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?